Tenax Therapeutics (TENX) EBT Margin (2011 - 2015)

Tenax Therapeutics (TENX) has 4 years of EBT Margin data on file, last reported at 9877.81% in Q2 2015.

• For the quarter ending Q2 2015, EBT Margin changed N/A year-over-year to 9877.81%; the trailing twelve-month figure through Jun 2016 stood at 29552.48% (down 2807545.0% YoY), and the FY2015 full-year result was 47276.5%, changed N/A from the prior year.
• EBT Margin fell to 9877.81% in Q2 2015, from 1410.18% in the prior quarter.
• In the past five years, EBT Margin ranged from a high of 6427.01% in Q2 2011 to a low of 11513.99% in Q3 2011.
• A 4-year average of 3525.52% and a median of 2546.01% in 2012 frame the typical range for EBT Margin.
• Peak annual rise in EBT Margin reached 1016289 bps in 2012, while the deepest fall reached 917777 bps in 2012.
• Tracing TENX's EBT Margin over 4 years: stood at 6298.92% in 2011, then surged by 95 bps to 304.33% in 2012, then slumped by 363 bps to 1410.18% in 2013, then sank by 600 bps to 9877.81% in 2015.
• Business Quant data shows TENX's EBT Margin at 9877.81% in Q2 2015, 1410.18% in Q2 2013, and 2341.27% in Q1 2013.